• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病和心血管疾病中的血浆蛋白质组生物标志物:一项纵向研究。

Plasma Proteomic Biomarkers in Alzheimer's Disease and Cardiovascular Disease: A Longitudinal Study.

机构信息

Department of Community of Acute and Chronic Care, School of Nursing, The George Washington University, Ashburn, VA 20147, USA.

Department of Biostatistics and Epidemiology, College of Public Health, East Tennessee State University, Johnson City, TN 37614, USA.

出版信息

Int J Mol Sci. 2024 Oct 6;25(19):10751. doi: 10.3390/ijms251910751.

DOI:10.3390/ijms251910751
PMID:39409080
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11477191/
Abstract

The co-occurrence of Alzheimer's disease (AD) and cardiovascular diseases (CVDs) in older adults highlights the necessity for the exploration of potential shared risk factors. A total of 566 adults were selected from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database, including 111 individuals with AD, 383 with mild cognitive impairment (MCI), and 410 with CVD. The multivariable linear mixed model (LMM) was used to investigate the associations of AD and CVD with longitudinal changes in 146 plasma proteomic biomarkers (measured at baseline and the 12-month follow-up). The LMM showed that 48 biomarkers were linked to AD and 46 to CVD ( < 0.05). Both AD and CVD were associated with longitudinal changes in 14 biomarkers (α1Micro, ApoH, β2M, BNP, complement C3, cystatin C, KIM1, NGAL, PPP, TIM1, THP, TFF3, TM, and VEGF), and both MCI and CVD were associated with 12 biomarkers (ApoD, AXL, BNP, Calcitonin, CD40, C-peptide, pM, PPP, THP, TNFR2, TTR, and VEGF), suggesting intricate connections between cognitive decline and cardiovascular health. Among these, the Tamm Horsfall Protein (THP) was associated with AD, MCI, CVD, and -ε4. This study provides valuable insights into shared and distinct biological markers and mechanisms underlying AD and CVD.

摘要

阿尔茨海默病(AD)和心血管疾病(CVDs)在老年人中的共同发生凸显了探索潜在共同风险因素的必要性。总共从阿尔茨海默病神经影像学倡议(ADNI)数据库中选择了 566 名成年人,包括 111 名 AD 患者、383 名轻度认知障碍(MCI)患者和 410 名 CVD 患者。多变量线性混合模型(LMM)用于研究 AD 和 CVD 与 146 种血浆蛋白质组生物标志物(在基线和 12 个月随访时测量)的纵向变化之间的关联。LMM 显示,48 种生物标志物与 AD 相关,46 种与 CVD 相关(<0.05)。AD 和 CVD 均与 14 种生物标志物(α1Micro、ApoH、β2M、BNP、补体 C3、胱抑素 C、KIM1、NGAL、PPP、TIM1、THP、TFF3、TM 和 VEGF)的纵向变化相关,MCI 和 CVD 均与 12 种生物标志物(ApoD、AXL、BNP、降钙素、CD40、C-肽、pM、PPP、THP、TNFR2、TTR 和 VEGF)相关,表明认知能力下降和心血管健康之间存在错综复杂的联系。其中,Tamm Horsfall Protein(THP)与 AD、MCI、CVD 和 ε4 相关。这项研究为 AD 和 CVD 的共同和独特的生物标志物和机制提供了有价值的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3af6/11477191/e7e8ebd3b9a1/ijms-25-10751-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3af6/11477191/e7e8ebd3b9a1/ijms-25-10751-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3af6/11477191/e7e8ebd3b9a1/ijms-25-10751-g001.jpg

相似文献

1
Plasma Proteomic Biomarkers in Alzheimer's Disease and Cardiovascular Disease: A Longitudinal Study.阿尔茨海默病和心血管疾病中的血浆蛋白质组生物标志物:一项纵向研究。
Int J Mol Sci. 2024 Oct 6;25(19):10751. doi: 10.3390/ijms251910751.
2
Levels of Angiotensin-Converting Enzyme and Apolipoproteins Are Associated with Alzheimer's Disease and Cardiovascular Diseases.血管紧张素转换酶和载脂蛋白水平与阿尔茨海默病和心血管疾病有关。
Cells. 2021 Dec 23;11(1):29. doi: 10.3390/cells11010029.
3
Predicting Longitudinal Cognitive Decline and Alzheimer's Conversion in Mild Cognitive Impairment Patients Based on Plasma Biomarkers.基于血浆生物标志物预测轻度认知障碍患者的纵向认知下降和阿尔茨海默病转化。
Cells. 2024 Jun 22;13(13):1085. doi: 10.3390/cells13131085.
4
Low testosterone levels relate to poorer cognitive function in women in an APOE-ε4-dependant manner.低睾丸激素水平与 APOE-ε4 依赖性女性认知功能较差有关。
Biol Sex Differ. 2024 Jun 5;15(1):45. doi: 10.1186/s13293-024-00620-4.
5
Peripheral Markers of Vascular Endothelial Dysfunction Show Independent but Additive Relationships with Brain-Based Biomarkers in Association with Functional Impairment in Alzheimer's Disease.外周血管内皮功能障碍标志物与阿尔茨海默病相关的脑内生物标志物具有独立但累加的关系,并与功能障碍相关。
J Alzheimers Dis. 2021;80(4):1553-1565. doi: 10.3233/JAD-200759.
6
Lower Serum Calcium as a Potentially Associated Factor for Conversion of Mild Cognitive Impairment to Early Alzheimer's Disease in the Japanese Alzheimer's Disease Neuroimaging Initiative.血清钙水平降低可能与轻度认知障碍向早期阿尔茨海默病转化有关:日本阿尔茨海默病神经影像学倡议研究。
J Alzheimers Dis. 2019;68(2):777-788. doi: 10.3233/JAD-181115.
7
Imaging proteomics for diagnosis, monitoring and prediction of Alzheimer's disease.用于阿尔茨海默病诊断、监测和预测的成像蛋白质组学
Neuroimage. 2014 Nov 15;102 Pt 2(Pt 2):657-65. doi: 10.1016/j.neuroimage.2014.08.041. Epub 2014 Aug 28.
8
Multivariate protein signatures of pre-clinical Alzheimer's disease in the Alzheimer's disease neuroimaging initiative (ADNI) plasma proteome dataset.阿尔茨海默病神经影像学倡议 (ADNI) 血浆蛋白质组学数据集中,临床前阿尔茨海默病的多变量蛋白质标志物。
PLoS One. 2012;7(4):e34341. doi: 10.1371/journal.pone.0034341. Epub 2012 Apr 2.
9
What Are the Reliable Plasma Biomarkers for Mild Cognitive Impairment? A Clinical 4D Proteomics Study and Validation.哪些是轻度认知障碍的可靠血浆生物标志物?一项临床 4D 蛋白质组学研究及验证。
Mediators Inflamm. 2024 May 27;2024:7709277. doi: 10.1155/2024/7709277. eCollection 2024.
10
Harnessing peripheral DNA methylation differences in the Alzheimer's Disease Neuroimaging Initiative (ADNI) to reveal novel biomarkers of disease.利用阿尔茨海默病神经影像学倡议(ADNI)中的外周 DNA 甲基化差异来揭示疾病的新型生物标志物。
Clin Epigenetics. 2020 Jun 15;12(1):84. doi: 10.1186/s13148-020-00864-y.

引用本文的文献

1
Locus coeruleus integrity correlates with plasma soluble Axl levels in Alzheimer's disease patients.在阿尔茨海默病患者中,蓝斑核完整性与血浆可溶性Axl水平相关。
Alzheimers Dement. 2025 Jul;21(7):e70434. doi: 10.1002/alz.70434.
2
Is the Relationship Between Cardiovascular Disease and Alzheimer's Disease Genetic? A Scoping Review.心血管疾病与阿尔茨海默病之间的关系是遗传的吗?一项范围综述。
Genes (Basel). 2024 Nov 25;15(12):1509. doi: 10.3390/genes15121509.

本文引用的文献

1
Copper metabolism-related Genes in entorhinal cortex for Alzheimer's disease.阿尔茨海默病患者内嗅皮层铜代谢相关基因。
Sci Rep. 2023 Oct 14;13(1):17458. doi: 10.1038/s41598-023-44656-9.
2
Unveiling the Hidden Power of Uromodulin: A Promising Potential Biomarker for Kidney Diseases.揭示尿调节蛋白的隐藏力量:一种有前景的肾脏疾病潜在生物标志物。
Diagnostics (Basel). 2023 Sep 28;13(19):3077. doi: 10.3390/diagnostics13193077.
3
Activation of TNF Receptor 2 Improves Synaptic Plasticity and Enhances Amyloid-β Clearance in an Alzheimer's Disease Mouse Model with Humanized TNF Receptor 2.
人源化 TNF 受体 2 阿尔茨海默病小鼠模型中 TNF 受体 2 的激活改善了突触可塑性并增强了淀粉样β清除。
J Alzheimers Dis. 2023;94(3):977-991. doi: 10.3233/JAD-221230.
4
Plasma β-microglobulin and cerebrospinal fluid biomarkers of Alzheimer's disease pathology in cognitively intact older adults: the CABLE study.血浆β-微球蛋白和阿尔茨海默病病理学的脑脊液生物标志物在认知正常的老年人中的研究:CABLE 研究。
Alzheimers Res Ther. 2023 Apr 1;15(1):69. doi: 10.1186/s13195-023-01217-6.
5
2023 Alzheimer's disease facts and figures.2023 年阿尔茨海默病事实和数据。
Alzheimers Dement. 2023 Apr;19(4):1598-1695. doi: 10.1002/alz.13016. Epub 2023 Mar 14.
6
Soluble and insoluble protein aggregates, endoplasmic reticulum stress, and vascular dysfunction in Alzheimer's disease and cardiovascular diseases.阿尔茨海默病和心血管疾病中的可溶性和不溶性蛋白聚集物、内质网应激和血管功能障碍。
Geroscience. 2023 Jun;45(3):1411-1438. doi: 10.1007/s11357-023-00748-y. Epub 2023 Feb 24.
7
Salivary inflammatory biomarkers are predictive of mild cognitive impairment and Alzheimer's disease in a feasibility study.在一项可行性研究中,唾液炎症生物标志物可预测轻度认知障碍和阿尔茨海默病。
Front Aging Neurosci. 2022 Nov 10;14:1019296. doi: 10.3389/fnagi.2022.1019296. eCollection 2022.
8
A TNF receptor 2 agonist ameliorates neuropathology and improves cognition in an Alzheimer's disease mouse model.TNF 受体 2 激动剂改善阿尔茨海默病小鼠模型的神经病理学和认知功能。
Proc Natl Acad Sci U S A. 2022 Sep 13;119(37):e2201137119. doi: 10.1073/pnas.2201137119. Epub 2022 Aug 29.
9
β2-Microglobulin exacerbates neuroinflammation, brain damage, and cognitive impairment after stroke in rats.β2微球蛋白会加重大鼠中风后的神经炎症、脑损伤和认知障碍。
Neural Regen Res. 2023 Mar;18(3):603-608. doi: 10.4103/1673-5374.350204.
10
A Novel Panel of Plasma Proteins Predicts Progression in Prodromal Alzheimer's Disease.一种新型血浆蛋白标志物 panel 可预测前驱期阿尔茨海默病的进展。
J Alzheimers Dis. 2022;88(2):549-561. doi: 10.3233/JAD-220256.